Subsequent Events

12 Months Ended

Dec. 31, 2022

Subsequent Event

Subsequent Events

18.        Subsequent Events

On January 27, 2023, Nighthawk Biosciences, Inc. terminated its license agreements with the University of Miami as these assets will not be developed further. The following agreements have been terminated:  

● License Agreement (UMIP-510) between the University of Miami and Zolovax, Inc. dated December 31, 2020.  

● License Agreement (UMSS-114 (previously UM97-14)) between the University of Miami and Heat Biologics, Inc. effective July 11, 2008, as amended.  

● License Agreement (UMSS114A) between the University of Miami and Heat Biologics I, Inc. effective February 18, 2011, as amended.

● License Agreement (UMD-107) between the University of Miami Heat Biologics I, Inc. effective February 18, 2011.

● License Agreement (UMIP-114/Strbo) between the University of Miami and Zolovax, Inc., effective October 24, 2016.

● License Agreement between the University of Miami and Pelican, effective November 19, 2013.

● License Agreement (I176) between the University of Miami and Heat Biologics II, Inc., effective December 12, 2010.

● License Agreement (03­31, 05­39) between the University of Miami and Heat Biologics II, Inc., effective July 11, 2008.